AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 52 min read$TJX

Klinger John sold $1.0M of TJX

Klinger John (SEVP, CFO) sold 6,235 shares of TJX COMPANIES INC /DE/ (TJX) at $160.77 ($1.00M total) on 2026-06-05.

Original reporting
SEC EDGAR · Klinger John
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TJX
Neutral
high confidence
Mentioned
$TJX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TJXNeutralLow
01

Why it matters

Insider sale disclosures are typically low-signal unless paired with other negative events (earnings miss, guidance cut, investigations). Here, only the transaction details are provided.

02

Market read

A same-day insider sale at TJX is disclosed; traders may note it for sentiment/positioning, but it is not a fundamental catalyst.

03

What to watch

The filing does not state a 10b5-1 plan; without context (taxes, planned diversification), interpreting directionality is unreliable.

Relevance 6/10Novelty 4/10Timing: Filed same day (2026-06-05) as the insider sale disclosure.

Background

The article is an SEC Form 4 insider transaction disclosure for TJX, reporting an open-market sale by the CFO.

Company-level read

Ticker impact

$TJXNeutralHigh confidence
Context

TJX CFO sold 6,235 shares in an open-market transaction disclosed via SEC Form 4 at ~$160.77/share.

Expected impact

Likely minimal near-term impact; any effect is more about positioning/interpretation than new information.

Evidence & confidence

This is a routine insider transaction with no 10b5-1 plan disclosed and no accompanying operational or financial catalyst.

Market effects

Sector

No direct sector read-through; insider selling at a single retailer is not a sector catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Officer sales can reflect diversification or liquidity needs rather than bearish views, especially absent any other negative catalyst.

Key entities

  • company
    TJX COMPANIES INC /DE/

    Issuer of the SEC Form 4 insider transaction; CFO sold shares on 2026-06-05.

  • person
    Klinger John

    TJX SEVP/CFO who executed the open-market sale disclosed in the filing.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TJX insider trading history →

Related articles

SEP 16
$TJXHighAI 8/10

TJX Raises Fiscal 2027 Outlook as Q2 Results Show Broad-Based Growth

TJX raised its fiscal 2027 profit and earnings outlook after Q2 results exceeded expectations. Adjusted earnings rose 11% to $1.22 per share, and net sales increased 5% to $15.18 billion. Management also increased its long-term store target. Marmaxx, the largest division, showed the weakest growth at 1%, while other divisions performed better.

finance.yahoo.com2 min
SEP 16
$TJXMedAI 8/10

Should Investors Buy TJX as Growth Improves but Valuation Stays Rich?

TJX reported strong Q2 results with rising sales and raised its fiscal 2027 earnings guidance to $5.15-$5.20 per share. The company plans to expand its store count to 7,500 and accelerate growth. However, its valuation remains high, with a forward P/S ratio of 2.06, above industry and historical averages. TJX's cash flow and shareholder returns are robust, but execution and cost pressures remain risks.

finance.yahoo.com2 min
SEP 16
$TJXHighAI 8/10

TJX Falls 17.4% in the Past Month as Strong Results Meet Key Risks

TJX Companies Inc. (TJX) shares fell 17.4% in the past month despite beating Q2 earnings estimates and raising its full-year outlook. Q2 sales rose 5% to $15.18B, but Marmaxx's 1% comparable sales growth missed expectations. Management cited merchandise mix issues. TJX faces cost pressures from wages, fuel, and currency fluctuations, with Q3 gross margin expected to decline. The stock's valuation remains high, trading at a premium to its sub-industry and historical median.

finance.yahoo.com2 min
SEP 11
$TJXMed

Tjx stock hits 52-week low at 125.5 USD

TJX Companies' stock hit a 52-week low of $125.49, down 26% from its high. Despite a 1-year decline of 9.66% and YTD losses of 17%, InvestingPro suggests it may be undervalued. Q2 fiscal 2027 results beat estimates, with $15.2B revenue and $1.22 EPS. Analysts have mixed views, with Jefferies downgrading to Hold, Bernstein maintaining Outperform, and UBS raising its target to $198.

investing.com2 min